Article Information
History
- August 29, 2023.
Article Versions
- Version 1 (August 25, 2023 - 20:24).
- You are currently viewing Version 2 of this article (August 29, 2023 - 08:54).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Charlotte E Rutter1,*,
- Martie Van Tongeren2,3,
- Tony Fletcher1,
- Sarah A Rhodes4,
- Yiqun Chen5,
- Ian Hall2,3,6,
- Nick Warren5 and
- Neil Pearce1
- 1Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK
- 2Division of Population Health, Health Services Research & Primary Care, School of Health Sciences, University of Manchester, Manchester, United Kingdom
- 3Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom
- 4Centre for Occupational and Environmental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
- 5Science Division, Health and Safety Executive, Buxton, UK
- 6Public Health, Advice, Guidance and Expertise, UK Health Security Agency, London, United Kingdom
- ↵*Corresponding author:
Department of Medical Statistics, London School of Hygiene and Tropical Medicine, Keppel St, London Charlotte.Rutter1{at}lshtm.ac.uk
Posted August 29, 2023.
Risk factors for SARS-Cov-2 infection at a United Kingdom electricity-generating company: a test-negative design case-control study
